Summit Health

Bend, Oregon 97701

4 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Diseases, Fibrosis, Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis (IPF), Interstitial Lung Disease, Interstitial Lung Disease Due to Connective Tissue Disease (Disorder), Interstitial Lung Disease With Progressive Fibrotic Phenotype in Diseases Classified Elsewhere, Interstitial Lung Disease With Systemic Sclerosis, Interstitial Lung Disease in Patients With Rheumatoid Arthritis, Lung Diseases, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis

Studies at this site

• An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) — Recruiting now
• A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD — Recruiting now
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH — Recruiting now
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis — Running, not enrolling
• A Study of Mosliciguat in PH-ILD — Running, not enrolling